首页> 外文OA文献 >Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

【2h】

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

机译：校正：血浆LySO-GB3作为生物标志物的疗效，用于从多特异性诊所选择高危患者的生物标志物进行遗传分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroki Maruyama; Kaori Miyata; Mariko Mikame; Atsumi Taguchi; Chu Guili; Masaru Shimura; Kei Murayama; Takeshi Inoue; Saori Yamamoto; Koichiro Sugimura; Koichi Tamita; Toshihiro Kawasaki; Jun Kajihara; Akifumi Onishi; Hitoshi Sugiyama; Teiko Sakai; Ichijiro Murata; Takamasa Oda; Shigeru Toyoda; Kenichiro Hanawa; Takeo Fujimura; Shigehisa Ura; Mimiko Matsumura; Hideki Takano; Satoshi Yamashita; Gaku Matsukura; Ryushi Tazawa; Tsuyoshi Shiga; Mio Ebato; Hiroshi Satoh; Satoshi Ishii;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis [J] . Maruyama Hiroki, Miyata Kaori, Mikame Mariko, Genetics in medicine . 2019,第1期

机译：血浆Lyso-GB3作为选择高风险患者的遗传分析，血浆Lyso-GB3作为生物标志物选择高危诊所的生物标志物
2. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (vol 21, pg 44, 2019) [J] . Maruyama Hiroki, Miyata Kaori, Mikame Mariko, Genetics in medicine . 2019,第8期

机译：血浆Lyso-GB3作为生物标志物的疗效，用于从多特异性诊所选择高风险患者的遗传分析（第21卷，PG 44,2019）
3. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (vol 21, pg 44, 2019) [J] . Maruyama Hiroki, Miyata Kaori, Mikame Mariko, Genetics in medicine . 2019,第5期

机译：血浆Lyso-GB3作为生物标志物的疗效，用于从多特异性诊所选择高风险患者的遗传分析（第21卷，PG 44,2019）
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Spatially resolved and bulk zinc analysis in biological samples of patients at different stages of Alzheimer's disease by high resolution inductively coupled plasma mass spectrometry [D] . Dong, Jiang 2008

机译：高分辨率电感耦合等离子体质谱法对阿尔茨海默氏病不同阶段患者生物样品中的空间分辨锌和大量锌进行分析
6. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis [O] . Hiroki Maruyama, Kaori Miyata, Mariko Mikame, -1

机译：从多专科诊所中选择血浆lyso-Gb3作为生物标志物从多专科诊所选择高危Fabry疾病患者的生物标记物的有效性
7. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis [O] . Hiroki Maruyama, Kaori Miyata, Mariko Mikame, 2018

机译：校正：血浆LySO-GB3作为生物标志物的疗效，用于从多特异性诊所选择高危患者的生物标志物进行遗传分析

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

著录项

引文网络

相似文献

相关主题

期刊订阅